Cargando…

Separate and Combined Effects of DNMT and HDAC Inhibitors in Treating Human Multi-Drug Resistant Osteosarcoma HosDXR150 Cell Line

Understanding the molecular mechanisms underlying multi-drug resistance (MDR) is one of the major challenges in current cancer research. A phenomenon which is common to both intrinsic and acquired resistance, is the aberrant alteration of gene expression in drug-resistant cancers. Although such dysr...

Descripción completa

Detalles Bibliográficos
Autores principales: Capobianco, Enrico, Mora, Antonio, La Sala, Dario, Roberti, Annalisa, Zaki, Nazar, Badidi, Elarbi, Taranta, Monia, Cinti, Caterina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995708/
https://www.ncbi.nlm.nih.gov/pubmed/24756038
http://dx.doi.org/10.1371/journal.pone.0095596
_version_ 1782312920312446976
author Capobianco, Enrico
Mora, Antonio
La Sala, Dario
Roberti, Annalisa
Zaki, Nazar
Badidi, Elarbi
Taranta, Monia
Cinti, Caterina
author_facet Capobianco, Enrico
Mora, Antonio
La Sala, Dario
Roberti, Annalisa
Zaki, Nazar
Badidi, Elarbi
Taranta, Monia
Cinti, Caterina
author_sort Capobianco, Enrico
collection PubMed
description Understanding the molecular mechanisms underlying multi-drug resistance (MDR) is one of the major challenges in current cancer research. A phenomenon which is common to both intrinsic and acquired resistance, is the aberrant alteration of gene expression in drug-resistant cancers. Although such dysregulation depends on many possible causes, an epigenetic characterization is considered a main driver. Recent studies have suggested a direct role for epigenetic inactivation of genes in determining tumor chemo-sensitivity. We investigated the effects of the inhibition of DNA methyltransferase (DNMT) and hystone deacethylase (HDAC), considered to reverse the epigenetic aberrations and lead to the re-expression of de novo methylated genes in MDR osteosarcoma (OS) cells. Based on our analysis of the HosDXR150 cell line, we found that in order to reduce cell proliferation, co-treatment of MDR OS cells with DNMT (5-Aza-dC, DAC) and HDAC (Trichostatin A, TSA) inhibitors is more effective than relying on each treatment alone. In re-expressing epigenetically silenced genes induced by treatments, a very specific regulation takes place which suggests that methylation and de-acetylation have occurred either separately or simultaneously to determine MDR OS phenotype. In particular, functional relationships have been reported after measuring differential gene expression, indicating that MDR OS cells acquired growth and survival advantage by simultaneous epigenetic inactivation of both multiple p53-independent apoptotic signals and osteoblast differentiation pathways. Furthermore, co-treatment results more efficient in inducing the re-expression of some main pathways according to the computed enrichment, thus emphasizing its potential towards representing an effective therapeutic option for MDR OS.
format Online
Article
Text
id pubmed-3995708
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-39957082014-04-25 Separate and Combined Effects of DNMT and HDAC Inhibitors in Treating Human Multi-Drug Resistant Osteosarcoma HosDXR150 Cell Line Capobianco, Enrico Mora, Antonio La Sala, Dario Roberti, Annalisa Zaki, Nazar Badidi, Elarbi Taranta, Monia Cinti, Caterina PLoS One Research Article Understanding the molecular mechanisms underlying multi-drug resistance (MDR) is one of the major challenges in current cancer research. A phenomenon which is common to both intrinsic and acquired resistance, is the aberrant alteration of gene expression in drug-resistant cancers. Although such dysregulation depends on many possible causes, an epigenetic characterization is considered a main driver. Recent studies have suggested a direct role for epigenetic inactivation of genes in determining tumor chemo-sensitivity. We investigated the effects of the inhibition of DNA methyltransferase (DNMT) and hystone deacethylase (HDAC), considered to reverse the epigenetic aberrations and lead to the re-expression of de novo methylated genes in MDR osteosarcoma (OS) cells. Based on our analysis of the HosDXR150 cell line, we found that in order to reduce cell proliferation, co-treatment of MDR OS cells with DNMT (5-Aza-dC, DAC) and HDAC (Trichostatin A, TSA) inhibitors is more effective than relying on each treatment alone. In re-expressing epigenetically silenced genes induced by treatments, a very specific regulation takes place which suggests that methylation and de-acetylation have occurred either separately or simultaneously to determine MDR OS phenotype. In particular, functional relationships have been reported after measuring differential gene expression, indicating that MDR OS cells acquired growth and survival advantage by simultaneous epigenetic inactivation of both multiple p53-independent apoptotic signals and osteoblast differentiation pathways. Furthermore, co-treatment results more efficient in inducing the re-expression of some main pathways according to the computed enrichment, thus emphasizing its potential towards representing an effective therapeutic option for MDR OS. Public Library of Science 2014-04-22 /pmc/articles/PMC3995708/ /pubmed/24756038 http://dx.doi.org/10.1371/journal.pone.0095596 Text en © 2014 Capobianco et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Capobianco, Enrico
Mora, Antonio
La Sala, Dario
Roberti, Annalisa
Zaki, Nazar
Badidi, Elarbi
Taranta, Monia
Cinti, Caterina
Separate and Combined Effects of DNMT and HDAC Inhibitors in Treating Human Multi-Drug Resistant Osteosarcoma HosDXR150 Cell Line
title Separate and Combined Effects of DNMT and HDAC Inhibitors in Treating Human Multi-Drug Resistant Osteosarcoma HosDXR150 Cell Line
title_full Separate and Combined Effects of DNMT and HDAC Inhibitors in Treating Human Multi-Drug Resistant Osteosarcoma HosDXR150 Cell Line
title_fullStr Separate and Combined Effects of DNMT and HDAC Inhibitors in Treating Human Multi-Drug Resistant Osteosarcoma HosDXR150 Cell Line
title_full_unstemmed Separate and Combined Effects of DNMT and HDAC Inhibitors in Treating Human Multi-Drug Resistant Osteosarcoma HosDXR150 Cell Line
title_short Separate and Combined Effects of DNMT and HDAC Inhibitors in Treating Human Multi-Drug Resistant Osteosarcoma HosDXR150 Cell Line
title_sort separate and combined effects of dnmt and hdac inhibitors in treating human multi-drug resistant osteosarcoma hosdxr150 cell line
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995708/
https://www.ncbi.nlm.nih.gov/pubmed/24756038
http://dx.doi.org/10.1371/journal.pone.0095596
work_keys_str_mv AT capobiancoenrico separateandcombinedeffectsofdnmtandhdacinhibitorsintreatinghumanmultidrugresistantosteosarcomahosdxr150cellline
AT moraantonio separateandcombinedeffectsofdnmtandhdacinhibitorsintreatinghumanmultidrugresistantosteosarcomahosdxr150cellline
AT lasaladario separateandcombinedeffectsofdnmtandhdacinhibitorsintreatinghumanmultidrugresistantosteosarcomahosdxr150cellline
AT robertiannalisa separateandcombinedeffectsofdnmtandhdacinhibitorsintreatinghumanmultidrugresistantosteosarcomahosdxr150cellline
AT zakinazar separateandcombinedeffectsofdnmtandhdacinhibitorsintreatinghumanmultidrugresistantosteosarcomahosdxr150cellline
AT badidielarbi separateandcombinedeffectsofdnmtandhdacinhibitorsintreatinghumanmultidrugresistantosteosarcomahosdxr150cellline
AT tarantamonia separateandcombinedeffectsofdnmtandhdacinhibitorsintreatinghumanmultidrugresistantosteosarcomahosdxr150cellline
AT cinticaterina separateandcombinedeffectsofdnmtandhdacinhibitorsintreatinghumanmultidrugresistantosteosarcomahosdxr150cellline